FGSN (F&G Annuities & Life, Inc. 7.300% Junior Subordinated Notes due 2065)
Insider Trading Activity
Every open-market purchase and sale reported by FGSN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-03 | Michael Joseph Nolan | Director | A | — | — |
| 2026-04-03 | Michael L Gravelle | EVP, General Counsel & Corp S | F | — | — |
| 2026-04-03 | Conor Murphy | President and CFO | F | — | — |
| 2026-04-03 | Douglas K Ammerman | Director | A | — | — |
| 2026-04-03 | RAYMOND R QUIRK | Director | A | — | — |
| 2026-03-13 | Celina J. Wang Doka | Director | Buy | — | — |
| 2026-03-13 | Christopher O Blunt | Chief Executive Officer | Buy | — | — |
| 2026-03-03 | Wendy J.B. Young | EVP, CLO & Treasurer | F | — | — |
| 2026-03-03 | Christopher O Blunt | Chief Executive Officer | F | — | — |
| 2026-03-03 | WILLIAM P FOLEY II | Executive Chairman | F | — | — |
| 2026-01-07 | RAYMOND R QUIRK | Director | MIXED | — | — |
| 2026-01-07 | Michael Joseph Nolan | Director | MIXED | — | — |
| 2026-01-07 | Douglas K Ammerman | Director | MIXED | — | — |
| 2026-01-02 | Christopher O Blunt | Chief Executive Officer | MIXED | — | — |
| 2025-12-31 | Fidelity National Financial, Inc. | 10%+ Owner | J | — | — |
| 2025-12-03 | Christopher O Blunt | Chief Executive Officer | F | — | — |
| 2025-12-03 | Wendy J.B. Young | EVP, CLO & Treasurer | F | — | — |
| 2025-12-03 | WILLIAM P FOLEY II | Executive Chairman | F | — | — |
| 2025-12-03 | John David Currier Jr. | EVP, Senior Advisor | F | — | — |
| 2025-12-03 | Leena Punjabi | EVP, Chief Investment Officer | F | — | — |
| 2025-11-19 | Christopher O Blunt | Chief Executive Officer | Buy | — | — |
| 2025-11-18 | Wendy J.B. Young | EVP, CLO & Treasurer | F | — | — |
| 2025-11-18 | Leena Punjabi | EVP, Chief Investment Officer | F | — | — |
| 2025-11-18 | WILLIAM P FOLEY II | Executive Chairman | F | — | — |
| 2025-11-18 | John David Currier Jr. | EVP, Senior Advisor | F | — | — |
| 2025-11-18 | Christopher O Blunt | Chief Executive Officer | F | — | — |
| 2025-11-13 | Michael L Gravelle | EVP, General Counsel & Corp S | A | — | — |
| 2025-11-13 | Douglas Martinez | Director | A | — | — |
| 2025-11-13 | Douglas K Ammerman | Director | A | — | — |
| 2025-11-13 | Conor Murphy | President and CFO | A | — | — |
| 2025-11-13 | Michael Joseph Nolan | Director | A | — | — |
| 2025-11-13 | Celina J. Wang Doka | Director | A | — | — |
| 2025-11-13 | Christopher O Blunt | Chief Executive Officer | A | — | — |
| 2025-11-13 | WILLIAM P FOLEY II | Executive Chairman | A | — | — |
| 2025-11-13 | John D Rood | Director | A | — | — |
| 2025-11-13 | Leena Punjabi | EVP, Chief Investment Officer | A | — | — |
| 2025-11-13 | Wendy J.B. Young | EVP, CLO & Treasurer | A | — | — |
| 2025-11-13 | RAYMOND R QUIRK | Director | A | — | — |
| 2025-10-03 | Douglas K Ammerman | Director | A | — | — |
| 2025-10-03 | Michael Joseph Nolan | Director | A | — | — |
| 2025-10-03 | RAYMOND R QUIRK | Director | A | — | — |
| 2025-09-19 | Leena Punjabi | EVP, Chief Investment Officer | Sell | — | — |
| 2025-09-02 | Christopher O Blunt | Chief Executive Officer | Buy | — | — |
| 2025-07-02 | Michael Joseph Nolan | Director | A | — | — |
| 2025-07-02 | Douglas K Ammerman | Director | A | — | — |
| 2025-07-02 | RAYMOND R QUIRK | Director | A | — | — |
| 2025-05-19 | Christopher O Blunt | Chief Executive Officer | Buy | — | — |
| 2025-05-16 | Christopher O Blunt | Chief Executive Officer | Buy | — | — |
| 2025-05-15 | Christopher O Blunt | Chief Executive Officer | Buy | — | — |
| 2025-05-12 | Christopher O Blunt | Chief Executive Officer | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 94,293,471 | — |
| — | Chief Executive Officer | 1,107,128 | — |
| — | Executive Chairman | 839,614 | — |
| — | Director | 311,489 | — |
| — | President and CFO | 195,212 | — |
| — | EVP, CLO & Treasurer | 105,154 | — |
| — | EVP, Chief Investment Officer | 80,910 | — |
| — | Director | 80,746 | — |
| — | EVP, Senior Advisor | 78,518 | — |
| — | Director | 64,086 | — |
| — | EVP, General Counsel & Corp S | 52,756 | — |
| — | Director | 43,009 | — |
| — | Director | 32,070 | — |
| — | Director | 26,532 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the FGSN quote page; the site-wide leaderboard is on the insider transactions hub.